Empowering Innovation with Next-Generation iPSC Solutions
At Aurorae Biolabs Inc., we turn your ideas into breakthroughs. Our custom cell services deliver science you can trust.
Looking for something custom? We love challenges—tell us what you need, and we'll respond within 24 hours with a free project evaluation.
iPSC Generation
Aurorae Biolabs Inc. offers comprehensive iPSC generation services from multiple source materials, including skin fibroblasts, PBMCs, LCLs, and other primary cells—derived from both healthy and disease-specific donors. Our optimized reprogramming workflow ensures high efficiency, genomic integrity, and pluripotency. Each iPSC line undergoes extensive characterization, including morphology assessment, pluripotency marker expression, karyotype analysis, and mycoplasma testing. Depending on your research or translational needs, we provide iPSC lines in research-grade or GLP-grade formats.
Gene Editing
Aurorae Biolabs Inc. provides precise and efficient gene editing solutions for iPSCs and a wide range of other cell types. Our expertise covers gene knockout, point mutation, large-fragment insertion or deletion, and advanced AID-based editing systems, enabling versatile genetic manipulation for both research and preclinical applications. Using state-of-the-art CRISPR/Cas and related technologies, we ensure high targeting accuracy, minimal off-target effects, and stable genome integrity. Each edited line is validated through sequencing and functional assays to confirm modifications.
Direct Differentiation
Aurorae Biolabs Inc. provides comprehensive direct differentiation services, converting iPSCs into more than 20 distinct cell types, including neurons, cardiomyocytes, hepatocytes, and other specialized cells. Differentiation can be performed in both single-cell formats or as 3D organoids, depending on your requirements. Each differentiated line undergoes rigorous quality control, with characterization benchmarks consistent with our off-the-shelf product datasheets, ensuring reproducibility, purity, and functional performance.
Cell-Based Assay
Aurorae Biolabs Inc. offers versatile cell-based assay services using iPSC-derived cells as well as other cell types provided by clients. Our assays are designed for drug screening, target validation, toxicity testing, and functional studies, enabling precise evaluation of therapeutic candidates. Leveraging well-characterized, high-quality cells and optimized assay platforms, we deliver reproducible and actionable results tailored to your research needs. Assay formats include single-cell analysis and high-content imaging.